Senseonics Holdings, Inc. (SENS)
Stock Price:
$0.382 USD
0.014 (3.91%)
Updated Oct 23, 2020 4:00 PM EDT - Market closed
Key Info
| Market Cap |
92.31M |
| Revenue (ttm) |
13.57M |
| Net Income (ttm) |
-105.22M |
| Shares Out |
241.40M |
| EPS (ttm) |
-0.51 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| Dividend |
n/a |
| Dividend Yield |
n/a |
Stock Quote
| Trading Day |
Oct 23, 2020 |
| Last Price |
$0.382 |
| Previous Close |
$0.368 |
| Change ($) |
0.014 |
| Change (%) |
3.91% |
| Day's Open |
0.372 |
| Day's Range |
0.370 - 0.383 |
| Day's Volume |
673,568 |
| 52-Week Range |
0.357 - 1.780 |
More Stats
| Market Cap |
92.31M |
| Enterprise Value |
131.91M |
| Earnings Date (est) |
Oct 28, 2020 |
| Ex-Dividend Date |
n/a |
| Shares Outstanding |
241.40M |
| Float |
154.24M |
| EPS (basic) |
-0.52 |
| EPS (diluted) |
-0.51 |
| FCF / Share |
-0.53 |
| Dividend |
n/a |
| Dividend Yield |
n/a |
| Earnings Yield |
n/a |
| FCF Yield |
n/a |
| Payout Ratio |
n/a |
| Shares Short |
24.43M |
| Short Ratio |
15.58 |
| Short % of Float |
15.84% |
| Beta |
0.48 |
| PE Ratio |
n/a |
| Forward PE |
n/a |
| P/FCF Ratio |
n/a |
| PS Ratio |
6.80 |
| PB Ratio |
12.45 |
| Revenue |
13.57M |
| Operating Income |
-122.60M |
| Net Income |
-105.22M |
| Free Cash Flow |
-116.46M |
| Net Cash |
-39.60M |
| Net Cash / Share |
-0.16 |
| Gross Margin |
-143.34% |
| Operating Margin |
-903.58% |
| Profit Margin |
-775.50% |
| FCF Margin |
-858.31% |
| ROA |
-110.07% |
| ROE |
-369.10% |
| ROIC |
-136.80% |
Stats based on trailing-twelve-month (ttm) numbers.
Analyst Summary
Analyst Ratings (7)
| Buy |
4 |
| Overweight |
0 |
| Hold |
3 |
| Underweight |
0 |
| Sell |
0 |
Price Target
$0.93*
(143.20% upside)
Low
0.40
Current: $0.382
High
1.25
Target: 0.93
*Average 12-month price target from 5 stock analysts.
Financial Performance
Financial numbers in millions USD.
Financial Overview
| Year | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 |
|---|
| Revenue | 21.30 | 18.91 | 6.37 | 0.33 | 0.04 | - |
| Revenue Growth | 12.63% | 196.77% | 1819.58% | 773.68% | - | - |
| Gross Profit | -19.45 | -8.15 | -3.39 | -0.33 | 0.04 | - |
| Operating Income | -131 | -87.58 | -56.31 | -42.43 | -28.81 | -18.70 |
| Net Income | -116 | -93.97 | -59.10 | -43.93 | -29.88 | -18.89 |
| Shares Outstanding | 189 | 157 | 116 | 89.24 | 7.00 | 1.91 |
| Earnings Per Share | -0.61 | -0.60 | -0.51 | -0.49 | -4.32 | -9.89 |
| Operating Cash Flow | -136 | -90.77 | -55.74 | -38.02 | -25.47 | -19.27 |
| Capital Expenditures | -1.05 | -0.99 | -0.35 | -0.48 | -0.20 | -0.03 |
| Free Cash Flow | -137 | -91.76 | -56.08 | -38.50 | -25.67 | -19.30 |
| Cash & Equivalents | 95.94 | 137 | 36.45 | 20.34 | 3.94 | 18.92 |
| Total Debt | 116 | 67.98 | 25.47 | 19.07 | 9.82 | 9.82 |
| Net Cash / Debt | -19.65 | 68.82 | 10.98 | 1.27 | -5.88 | 9.11 |
| Assets | 133 | 160 | 45.94 | 22.27 | 5.42 | 20.00 |
| Liabilities | 141 | 88.71 | 38.68 | 27.15 | 15.12 | 12.08 |
| Book Value | -8.65 | 71.26 | 7.27 | -4.88 | -9.70 | 7.91 |
Numbers in millions USD, except per-share numbers.
Company Details
| Full Name |
Senseonics Holdings, Inc. |
| Country |
United States |
| Employees |
191 |
| CEO |
Timothy T. Goodnow |
Stock Information
| Ticker Symbol |
SENS |
| Stock Exchange |
NYSE American |
| Sector |
Healthcare |
| Industry |
Diagnostics & Research |
| Unique Identifier |
NYSEAMERICAN: SENS |
Description
Senseonics Holdings, a medical technology company, develops and commercializes continuous glucose monitoring (CGM) systems for people with diabetes primarily in Europe. Its products include Eversense and Eversense XL, which are implantable CGM systems to measure glucose levels in people with diabetes for a period of up to 90 and 180 days. Senseonics Holdings, Inc. was founded in 1996 and is headquartered in Germantown, Maryland.